These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17517601)

  • 1. Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication.
    Jiang P; Faase JA; Toyoda H; Paul A; Wimmer E; Gorbalenya AE
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9457-62. PubMed ID: 17517601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will the polio niche remain vacant?
    Rieder E; Gorbalenya AE; Xiao C; He Y; Baker TS; Kuhn RJ; Rossmann MG; Wimmer E
    Dev Biol (Basel); 2001; 105():111-22; discussion 149-50. PubMed ID: 11763320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity.
    Mueller S; Papamichail D; Coleman JR; Skiena S; Wimmer E
    J Virol; 2006 Oct; 80(19):9687-96. PubMed ID: 16973573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
    Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E
    J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses.
    Jegouic S; Joffret ML; Blanchard C; Riquet FB; Perret C; Pelletier I; Colbere-Garapin F; Rakoto-Andrianarivelo M; Delpeyroux F
    PLoS Pathog; 2009 May; 5(5):e1000412. PubMed ID: 19412342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses.
    Holmblat B; Jégouic S; Muslin C; Blondel B; Joffret ML; Delpeyroux F
    mBio; 2014 Aug; 5(4):e01119-14. PubMed ID: 25096874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence.
    Combelas N; Holmblat B; Joffret ML; Colbère-Garapin F; Delpeyroux F
    Viruses; 2011 Aug; 3(8):1460-84. PubMed ID: 21994791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon.
    Arita M; Nagata N; Sata T; Miyamura T; Shimizu H
    J Gen Virol; 2006 Nov; 87(Pt 11):3317-3327. PubMed ID: 17030866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Transgenic Mouse Model of Poliomyelitis.
    Koike S; Nagata N
    Methods Mol Biol; 2016; 1387():129-44. PubMed ID: 26983733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence.
    Gromeier M; Bossert B; Arita M; Nomoto A; Wimmer E
    J Virol; 1999 Feb; 73(2):958-64. PubMed ID: 9882296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.
    Khan S; Toyoda H; Linehan M; Iwasaki A; Nomoto A; Bernhardt G; Cello J; Wimmer E
    J Gen Virol; 2014 Aug; 95(Pt 8):1668-1676. PubMed ID: 24784416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reevaluate the effect of G-480 point mutation that determines the neurovirulence of type I vaccine polioviruses].
    Zhang Y; Yan DM; Wang DY; Zhao R; Zhang DY; Ye XF; Zhu SL; An HQ; Xu WB
    Bing Du Xue Bao; 2007 Jan; 23(1):1-8. PubMed ID: 17886713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.
    Arita M; Zhu SL; Yoshida H; Yoneyama T; Miyamura T; Shimizu H
    J Virol; 2005 Oct; 79(20):12650-7. PubMed ID: 16188967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biological monitoring of the polioviruses circulation in Belarus].
    Beletskaia TS; Fel'dman EV; Samoĭlovich EO; Scheslenok EP; Kapustik LA
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):29-36. PubMed ID: 12630350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
    Pavio N; Couderc T; Girard S; Sgro JY; Blondel B; Colbère-Garapin F
    Virology; 2000 Sep; 274(2):331-42. PubMed ID: 10964776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus. A meeting report of the WHO Global Programme for Vaccines and Immunization and the WHO Biologicals Unit, Geneva, Switzerland, 26-28 September 1996.
    Vaccine; 1997 Mar; 15(4):341-5. PubMed ID: 9141201
    [No Abstract]   [Full Text] [Related]  

  • 19. Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan.
    Okemoto-Nakamura Y; Someya K; Yamaji T; Saito K; Takeda M; Hanada K
    Sci Rep; 2021 Mar; 11(1):6746. PubMed ID: 33762624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of unintentional propagation of poliovirus can be minimized by using human cell lines lacking the functional CD155 gene.
    Koike S
    Microbiol Immunol; 2020 Dec; 64(12):835-839. PubMed ID: 32902876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.